Ahrens Investment Partners LLC Bausch Health Companies Inc. Transaction History
Ahrens Investment Partners LLC
- $200 Million
- Q1 2023
A detailed history of Ahrens Investment Partners LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 205 shares of BHC stock, worth $1,795. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205Holding current value
$1,795% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
254MCall Options Held
5.47MPut Options Held
16.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$304 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$258 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$232 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$137 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$114 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.17B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...